Clozapine for medication-related pathological gambling in Parkinson disease
β Scribed by Alessandro Rotondo; Domenico Bosco; Massimiliano Plastino; Arturo Consoli; Francesca Bosco
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 290 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This case series, as well as a subsequent prospective survey of 100 PD patients, was presented as a poster at the Association of British Neurologists autumn meeting, October 2006 in London.
## Abstract Pathological gambling (PG) is a psychiatric disorder characterized by loss of control of gambling, which has repercussions on family, personal, and professional life. Several recent studies have reported the relationship between PG and the treatment of Parkinson's disease (PD), but no p
## Abstract The purpose of this study was to investigate the neuropsychological correlates of pathological gambling (PG) in Parkinson's disease (PD). Fifteen patients with PD affected by PG (identified based on DSMβIV criteria; PD+PG) without clinically evident dementia were compared with 15 nondem
## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopaβinduced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5β25 mg daily, because